2026 Global: Biocompatible 3D Printing Materials Market-Competitive Review (2032) report
Description
The 2026 Global: Biocompatible 3D Printing Materials Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for biocompatible 3d printing materials market by geography and historical trend. The scope of the report extends to sizing of the biocompatible 3d printing materials market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
3D Systems, Stratasys, Evonik Industries, Formlabs, EOS, Renishaw, EnvisionTEC (now part of Desktop Metal), Materialise, BASF Forward AM, and Cellink (BICO) are among the ten major companies shaping the biocompatible 3D printing materials market, each offering materials, platforms, or integrated solutions for medical and dental applications. 3D Systems supplies a broad portfolio of medical-grade polymers and resins and partners with healthcare providers to deliver patient-specific implants and surgical guides, positioning it as a leader in clinical applications and certified medical workflows. Stratasys is prominent for its biocompatible PolyJet and high-performance polymer offerings (MED-series and biocompatible ABS/PEEK options), extensive clinical certifications for dental and surgical uses, and strategic collaborations to expand bioresorbable and regenerative materials. Evonik focuses on specialty biomaterials and high-performance polymers (including medical-grade PEEK filaments and biofunctional additives) that target implantable and long-term contact applications, leveraging chemical expertise to meet stringent sterilization and ISO 10993 biocompatibility requirements. Formlabs has grown rapidly in medical-grade resin development and desktop-to-clinic workflows, offering certified dental and surgical resins that support point-of-care customization and lower-cost entry for clinics and labs. EOS and Renishaw lead on metal and polymer platforms for implantable devices and prosthetics, with EOS expanding regional capacity and Renishaw emphasizing precision metal additive manufacturing for orthopedics and dental markets. EnvisionTEC (Desktop Metal) historically supplied photopolymer and biocompatible dental resins and continues under new ownership to integrate materials and hardware for dental and medical device producers. Materialise contributes software-driven, certified manufacturing services and materials expertise for patient-specific devices, combining regulatory know-how with polymer processing to scale CE- and FDA-compliant products. BASF Forward AM brings polymer chemistry scale and formulation capability to the market, developing certified biocompatible photopolymers and engineering plastics for healthcare customers while leveraging global materials supply chains. Cellink (BICO) focuses on bioinks and biofabrication materials for tissue engineering and regenerative applications, spanning printable hydrogels, cell-laden bioinks, and partnerships to translate bioprinting research toward clinical and preclinical workflows.
Collectively these companies cover the primary material classes used in biocompatible additive manufacturing—medical-grade photopolymers, engineering thermoplastics (including PEEK and medical ABS), metal alloys for implants, and bioinks for tissue engineering—while pursuing regulatory approvals, clinical partnerships, and supply-chain expansions to serve dental, orthopedic, surgical guide, implantable device, and regenerative-medicine markets. Market reports and industry analyses consistently list this group among top players, though vendor rankings vary by source and segment focus: polymer specialists and resin providers (Formlabs, BASF, Evonik) dominate photopolymer and polymer device segments, machine-and-material integrators (3D Systems, Stratasys, EOS, Renishaw) lead device-certified workflows, and biofabrication specialists (Cellink, EnvisionTEC/ Desktop Metal) address bioprinting and dental niches. Ongoing trends shaping vendor strategies include development of ISO 10993–certified materials, collaborations to create bioresorbable and collagen-based materials, regional manufacturing expansions in APAC, and convergence of software, materials, and validated clinical workflows to accelerate point-of-care adoption and regulatory clearance for patient-specific products.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for biocompatible 3d printing materials market by geography and historical trend. The scope of the report extends to sizing of the biocompatible 3d printing materials market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
3D Systems, Stratasys, Evonik Industries, Formlabs, EOS, Renishaw, EnvisionTEC (now part of Desktop Metal), Materialise, BASF Forward AM, and Cellink (BICO) are among the ten major companies shaping the biocompatible 3D printing materials market, each offering materials, platforms, or integrated solutions for medical and dental applications. 3D Systems supplies a broad portfolio of medical-grade polymers and resins and partners with healthcare providers to deliver patient-specific implants and surgical guides, positioning it as a leader in clinical applications and certified medical workflows. Stratasys is prominent for its biocompatible PolyJet and high-performance polymer offerings (MED-series and biocompatible ABS/PEEK options), extensive clinical certifications for dental and surgical uses, and strategic collaborations to expand bioresorbable and regenerative materials. Evonik focuses on specialty biomaterials and high-performance polymers (including medical-grade PEEK filaments and biofunctional additives) that target implantable and long-term contact applications, leveraging chemical expertise to meet stringent sterilization and ISO 10993 biocompatibility requirements. Formlabs has grown rapidly in medical-grade resin development and desktop-to-clinic workflows, offering certified dental and surgical resins that support point-of-care customization and lower-cost entry for clinics and labs. EOS and Renishaw lead on metal and polymer platforms for implantable devices and prosthetics, with EOS expanding regional capacity and Renishaw emphasizing precision metal additive manufacturing for orthopedics and dental markets. EnvisionTEC (Desktop Metal) historically supplied photopolymer and biocompatible dental resins and continues under new ownership to integrate materials and hardware for dental and medical device producers. Materialise contributes software-driven, certified manufacturing services and materials expertise for patient-specific devices, combining regulatory know-how with polymer processing to scale CE- and FDA-compliant products. BASF Forward AM brings polymer chemistry scale and formulation capability to the market, developing certified biocompatible photopolymers and engineering plastics for healthcare customers while leveraging global materials supply chains. Cellink (BICO) focuses on bioinks and biofabrication materials for tissue engineering and regenerative applications, spanning printable hydrogels, cell-laden bioinks, and partnerships to translate bioprinting research toward clinical and preclinical workflows.
Collectively these companies cover the primary material classes used in biocompatible additive manufacturing—medical-grade photopolymers, engineering thermoplastics (including PEEK and medical ABS), metal alloys for implants, and bioinks for tissue engineering—while pursuing regulatory approvals, clinical partnerships, and supply-chain expansions to serve dental, orthopedic, surgical guide, implantable device, and regenerative-medicine markets. Market reports and industry analyses consistently list this group among top players, though vendor rankings vary by source and segment focus: polymer specialists and resin providers (Formlabs, BASF, Evonik) dominate photopolymer and polymer device segments, machine-and-material integrators (3D Systems, Stratasys, EOS, Renishaw) lead device-certified workflows, and biofabrication specialists (Cellink, EnvisionTEC/ Desktop Metal) address bioprinting and dental niches. Ongoing trends shaping vendor strategies include development of ISO 10993–certified materials, collaborations to create bioresorbable and collagen-based materials, regional manufacturing expansions in APAC, and convergence of software, materials, and validated clinical workflows to accelerate point-of-care adoption and regulatory clearance for patient-specific products.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.